Based on the immunosuppressive effects of AhR ligands on autoimmune diseases, such as EAE, it would be reasonable to propound that activation of AhR in the tumor microenvironment corresponds to increased numbers of Treg cells, which could also account for the tumor-promoting properties of TCDD [122]. This evidence concerns the gene AHR and autoimmune disease.